Author Search Results :: UTM Library Massive Scholar Tracking

1

A parsimonious model to validate cost-effectiveness analyses on preventive health care by Afschin Gandjour

Published 2021-11-01

Get full text

Article
2

Was EU’s COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations by Afschin Gandjour

Published 2022-11-01

Get full text

Article
3

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency by Afschin Gandjour

Published 2020-03-01

Get full text

Article
4

Long COVID: Costs for the German economy and health care and pension system by Afschin Gandjour

Published 2023-06-01

Get full text

Article
5

Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation by Afschin Gandjour

Published 2024-03-01

Get full text

Article
6

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results. by Afschin Gandjour

Published 2020-01-01

Get full text

Article
7

Optimal allocation of scarce PCR tests during the COVID-19 pandemic. by Afschin Gandjour

Published 2023-01-01

Get full text

Article
8

COVID-19 and the forgone health benefits of elective operations by Afschin Gandjour

Published 2022-12-01

Get full text

Article
9

Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer’s perspective by Afschin Gandjour

Published 2022-01-01

Get full text

Article
10

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG by Afschin Gandjour

Published 2020-04-01

Get full text

Article
11

The price of curing cancer by Afschin Gandjour

Published 2021-12-01

Get full text

Article
12

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results by Afschin Gandjour, George Vousden

Published 2020-01-01

Get full text

Article
13

To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective by Charles Christian Adarkwah, Afschin Gandjour, Maren Akkerman, Silvia Evers

Published 2013-05-01

Get full text

Article
14

Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands--a Markov model. by Charles Christian Adarkwah, Afschin Gandjour, Maren Akkerman, Silvia M Evers

Published 2011-01-01

Get full text

Article
15

Costs of patients with chronic kidney disease in Germany. by Afschin Gandjour, Wencke Armsen, Wolfgang Wehmeyer, Jan Multmeier, Ulrich Tschulena

Published 2020-01-01

Get full text

Article